Apotex Health Corp has scheduled its financial results announcement for November 12, 2026.
Apotex Health Corp will announce its second quarter fiscal 2027 financial results on November 12, 2026. The company will also host a conference call to discuss these results, which may provide insights into its financial health and operational strategies.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeMarket cap
$7.42B
52W high
$40.11
52W low
$26.01
1W change
-1.36%
Analyst Price Targets
Based on analyst covering APTX · as of Sep 23, 2026
Wall Street analysts forecast APTX stock price to rise 35.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.37
+35.5% Upside
Previously C$41.23 on Sep 17, 2026
Current Price
C$30.54
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
46.7%
Annualized
90-Day Vol
47.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$25.55
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$28.78 | C$24.50 – C$33.80 |
| 60 trading days | C$27.11 | C$21.59 – C$34.05 |
| 90 trading days | C$25.55 | C$19.33 – C$33.76 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should prepare for potentially significant updates regarding Apotex's financial performance during the upcoming call.
Last Close: C$30.68, Down 5.94% on the Day
The stock has experienced a decline of 9.28% over the past month, indicating potential market concerns leading up to the earnings announcement.
Bull case
If Apotex reports stronger-than-expected financial results, it could boost investor confidence and positively impact the stock price.
Bear case
On the other hand, disappointing results or negative guidance could lead to further declines in the stock price.
Upcoming Financial Results Announcement
Advertisement
Apotex Health Corp has announced that it will release its financial results for the second quarter of fiscal 2027 on November 12, 2026. This announcement will be accompanied by a conference call, where the company will provide insights into its performance during this period. As of the last trading session, Apotex's stock closed at C$30.68, reflecting a decline of 5.94% on the day and a 1.36% drop over the past week.
Current Stock Performance Overview
In the past month, Apotex's stock has decreased by 9.28%, indicating market concerns leading up to the earnings announcement. The stock is currently trading below both its 50-day moving average of C$34.03 and its 200-day moving average of C$33.87, down approximately 9.9% and 9.4%, respectively. Additionally, the stock is positioned within a 52-week range of C$26.01 to C$40.11, currently at 33% of that range. The trading volume for the day was 127,293 shares, which is about 61% of the 20-day average volume of 754,004 shares.
What to Watch Ahead of the Conference Call
Investors should pay close attention to the upcoming conference call on November 12, as it will likely include discussions on revenue trends, profit margins, and future guidance. Currently, Apotex has a market cap of C$7,419,363,840, with a profit margin of -0.9% and an earnings per share (EPS) of -0.14. The average analyst target for the stock is C$41.37, suggesting an implied move of +34.9% to that target. Any unexpected news during the call could lead to significant market reactions.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
